Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by KGNU - How On Earth. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by KGNU - How On Earth or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

GLP-1 and Blindness

26:58
 
Share
 

Manage episode 487940984 series 49299
Content provided by KGNU - How On Earth. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by KGNU - How On Earth or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
photo of intermediate macular degeneration c National Institutes of Health

We talk with scientists who report that a common weight loss/diabetes drug known as a GLP-1 receptor agonist (Wegovy, Ozempic for instance) is associated with an increased risk of blindness. The study was published last week in the Journal of the American Medical Association Ophthalmology, about a form of blindness known as “wet” macular degeneration. The scientists we talk with today are Marko Popovic and Reut Shor. We also refer to a different, unrelated study, underway, to evaluate a ketogenic diet and eye health, specifically, whether or not a ketogenic diet can reduce diabetes while providing better protection to the eye.

Executive Producer: Joel Parker
Show Producer: Shelley Schlender

  continue reading

736 episodes

Artwork

GLP-1 and Blindness

KGNU - How On Earth

0-10 subscribers

published

iconShare
 
Manage episode 487940984 series 49299
Content provided by KGNU - How On Earth. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by KGNU - How On Earth or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
photo of intermediate macular degeneration c National Institutes of Health

We talk with scientists who report that a common weight loss/diabetes drug known as a GLP-1 receptor agonist (Wegovy, Ozempic for instance) is associated with an increased risk of blindness. The study was published last week in the Journal of the American Medical Association Ophthalmology, about a form of blindness known as “wet” macular degeneration. The scientists we talk with today are Marko Popovic and Reut Shor. We also refer to a different, unrelated study, underway, to evaluate a ketogenic diet and eye health, specifically, whether or not a ketogenic diet can reduce diabetes while providing better protection to the eye.

Executive Producer: Joel Parker
Show Producer: Shelley Schlender

  continue reading

736 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play